Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 246

1.

ACLY (ATP Citrate Lyase) Mediates Radioresistance in Head and Neck Squamous Cell Carcinomas and is a Novel Predictive Radiotherapy Biomarker.

Göttgens EL, van den Heuvel CN, de Jong MC, Kaanders JH, Leenders WP, Ansems M, Bussink J, Span PN.

Cancers (Basel). 2019 Dec 7;11(12). pii: E1971. doi: 10.3390/cancers11121971.

2.

Radiotherapy in the treatment of extracranial hemangiopericytoma/solitary fibrous tumor: Study from the Rare Cancer Network.

Krengli M, Cena T, Zilli T, Jereczek-Fossa BA, De Bari B, Villa Freixa S, Kaanders JHAM, Torrente S, Pasquier D, Sole CV, Lutsyk M, Dincbas FO, Habboush Y, Fariselli L, Dragan T, Baumert BG, Khanfir K, Ugurluer G, Thariat J.

Radiother Oncol. 2019 Dec 2;144:114-120. doi: 10.1016/j.radonc.2019.11.011. [Epub ahead of print]

PMID:
31805515
3.

Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypes.

Meijer TWH, Looijen-Salamon MG, Lok J, van den Heuvel M, Tops B, Kaanders JHAM, Span PN, Bussink J.

Thorac Cancer. 2019 Dec;10(12):2289-2299. doi: 10.1111/1759-7714.13226. Epub 2019 Oct 30.

4.

18F-FDG-PET/CT-based treatment planning for definitive (chemo)radiotherapy in patients with head and neck squamous cell carcinoma improves regional control and survival.

van den Bosch S, Doornaert PAH, Dijkema T, Zwijnenburg EM, Verhoef LCG, Hoeben BAW, Kasperts N, Smid EJ, Terhaard CHJ, Kaanders JHAM.

Radiother Oncol. 2019 Aug 19. pii: S0167-8140(19)33018-X. doi: 10.1016/j.radonc.2019.07.025. [Epub ahead of print]

5.

Time patterns of recurrence and second primary tumors in a large cohort of patients treated for oral cavity cancer.

Brands MT, Smeekens EAJ, Takes RP, Kaanders JHAM, Verbeek ALM, Merkx MAW, Geurts SME.

Cancer Med. 2019 Sep;8(12):5810-5819. doi: 10.1002/cam4.2124. Epub 2019 Aug 10.

6.

Targeted Intervention to Improve the Quality of Head and Neck Radiation Therapy Treatment Planning in the Netherlands: Short and Long-Term Impact.

Verbakel WFAR, Doornaert PAH, Raaijmakers CPJ, Bos LJ, Essers M, van de Kamer JB, Dahele M, Terhaard CHJ, Kaanders JHAM.

Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):514-524. doi: 10.1016/j.ijrobp.2019.07.005. Epub 2019 Jul 12.

PMID:
31306734
7.

Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study).

Driessen CM, Ham JC, Te Loo M, van Meerten E, van Lamoen M, Hakobjan MH, Takes RP, van der Graaf WT, Kaanders JH, Coenen MJH, van Herpen CM.

Cancers (Basel). 2019 Apr 17;11(4). pii: E551. doi: 10.3390/cancers11040551.

8.

Prophylactic antibiotics reduce hospitalisations and cost in locally advanced head and neck cancer patients treated with chemoradiotherapy: A randomised phase 2 study.

Ham JC, Driessen CM, Hendriks MP, Fiets E, Kreike B, Hoeben A, Slingerland M, van Opstal CC, Kullberg BJ, Jonker MA, Adang EM, Kaanders JH, van der Graaf WT, van Herpen CM.

Eur J Cancer. 2019 May;113:32-40. doi: 10.1016/j.ejca.2019.02.013. Epub 2019 Apr 6.

PMID:
30965213
9.

Erratum: "Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers" [Med. Phys. 45 (7), 3449-3459 (2018)].

Deist TM, Dankers FJWM, Valdes G, Wijsman R, Hsu IC, Oberije C, Lustberg T, van Soest J, Hoebers F, Jochems A, El Naqa I, Wee L, Morin O, Raleigh DR, Bots W, Kaanders JH, Belderbos J, Kwint M, Solberg T, Monshouwer R, Bussink J, Dekker A, Lambin P.

Med Phys. 2019 Feb;46(2):1080-1087. doi: 10.1002/mp.13329. Epub 2019 Jan 7. No abstract available.

PMID:
30730570
10.

Ototoxicity in locally advanced head and neck cancer patients treated with induction chemotherapy followed by intermediate or high-dose cisplatin-based chemoradiotherapy.

Driessen CML, Leijendeckers J, Snik A, van der Graaf WTA, de Boer JP, Gelderblom H, Kaanders JHAM, Takes R, van Herpen CML.

Head Neck. 2019 Feb;41(2):488-494. doi: 10.1002/hed.25434. Epub 2018 Dec 7.

PMID:
30536479
11.

Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial.

Eekers DBP, Roelofs E, Cubillos-Mesías M, Niël C, Smeenk RJ, Hoeben A, Minken AWH, Granzier M, Janssens GO, Kaanders JHAM, Lambin P, Troost EGC.

Acta Oncol. 2019 Jan;58(1):57-65. doi: 10.1080/0284186X.2018.1529424. Epub 2018 Nov 26.

PMID:
30474448
12.

Image Guided Brachytherapy for Cancer of the Nasal Vestibule: Local Control and Cosmesis.

Czerwinski MD, van Leeuwen RGH, Kaanders JHAM, Zwijnenburg EM, Lipman D, Takes RP, Verhoef CG.

Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(4):913-921. doi: 10.1016/j.ijrobp.2018.11.018. Epub 2018 Nov 17.

PMID:
30458233
13.

Surgery, radiotherapy or a combined modality for jugulotympanic paraganglioma of Fisch class C and D.

Jansen TTG, Kaanders JHAM, Beute GN, Timmers HJLM, Marres HAM, Kunst HPM.

Clin Otolaryngol. 2018 Dec;43(6):1566-1572. doi: 10.1111/coa.13216. Epub 2018 Sep 26.

PMID:
30160027
14.

Tumor to cervical spinal cord standardized uptake ratio (SUR) improves the reproducibility of 18F-FDG-PET based tumor segmentation in head and neck squamous cell carcinoma in a multicenter setting.

van den Bosch S, Dijkema T, Philippens MEP, Terhaard CHJ, Hoebers FJP, Kaanders JHAM, Oyen WJG.

Radiother Oncol. 2019 Jan;130:39-45. doi: 10.1016/j.radonc.2018.06.037. Epub 2018 Jul 10.

15.

Clinicopathological characteristics and outcome of 31 patients with ETV6-NTRK3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glands.

Boon E, Valstar MH, van der Graaf WTA, Bloemena E, Willems SM, Meeuwis CA, Slootweg PJ, Smit LA, Merkx MAW, Takes RP, Kaanders JHAM, Groenen PJTA, Flucke UE, van Herpen CML.

Oral Oncol. 2018 Jul;82:29-33. doi: 10.1016/j.oraloncology.2018.04.022. Epub 2018 May 11.

16.

Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers.

Deist TM, Dankers FJWM, Valdes G, Wijsman R, Hsu IC, Oberije C, Lustberg T, van Soest J, Hoebers F, Jochems A, El Naqa I, Wee L, Morin O, Raleigh DR, Bots W, Kaanders JH, Belderbos J, Kwint M, Solberg T, Monshouwer R, Bussink J, Dekker A, Lambin P.

Med Phys. 2018 Jul;45(7):3449-3459. doi: 10.1002/mp.12967. Epub 2018 Jun 13. Erratum in: Med Phys. 2019 Feb;46(2):1080-1087.

17.

Implications of improved diagnostic imaging of small nodal metastases in head and neck cancer: Radiotherapy target volume transformation and dose de-escalation.

van den Bosch S, Vogel WV, Raaijmakers CP, Dijkema T, Terhaard CHJ, Al-Mamgani A, Kaanders JHAM.

Radiother Oncol. 2018 Sep;128(3):472-478. doi: 10.1016/j.radonc.2018.04.020. Epub 2018 May 3. Review.

18.

A meta-analysis on the surgical management of paraganglioma of the carotid body per Shamblin class.

Jansen TTG, Marres HAM, Kaanders JHAM, Kunst HPM.

Clin Otolaryngol. 2018 Apr 15. doi: 10.1111/coa.13116. [Epub ahead of print]

PMID:
29656606
19.

Quality of life of patients with locally advanced head and neck cancer treated with induction chemotherapy followed by cisplatin-containing chemoradiotherapy in the Dutch CONDOR study: a randomized controlled trial.

Driessen CML, Groenewoud JMM, de Boer JP, Gelderblom H, van der Graaf WTA, Prins JB, Kaanders JHAM, van Herpen CML.

Support Care Cancer. 2018 Apr;26(4):1233-1242. doi: 10.1007/s00520-017-3946-7. Epub 2017 Dec 11.

20.

Results of a systematic literature review of treatment modalities for jugulotympanic paraganglioma, stratified per Fisch class.

Jansen TTG, Timmers HJLM, Marres HAM, Kaanders JHAM, Kunst HPM.

Clin Otolaryngol. 2018 Apr;43(2):652-661. doi: 10.1111/coa.13046. Epub 2018 Jan 3.

PMID:
29222838
21.

Correction to: Automated IMRT planning in Pinnacle-A study in head-and-neck cancer.

Kusters JMAM, Bzdusek K, Kumar P, van Kollenburg PGM, Kunze-Busch MC, Wendling M, Dijkema T, Kaanders JHAM.

Strahlenther Onkol. 2017 Dec;193(12):1077-1078. doi: 10.1007/s00066-017-1230-x.

PMID:
29080045
22.

Local control in sinonasal malignant melanoma: Comparing conventional to hypofractionated radiotherapy.

Lansu J, Klop WM, Heemsbergen W, Navran A, Al-Mamgani A, Langendijk JA, Kaanders JH, Terhaard C, Karakullukcu B, Hamming-Vrieze O.

Head Neck. 2018 Jan;40(1):86-93. doi: 10.1002/hed.24979. Epub 2017 Oct 16.

PMID:
29044881
23.

Direct inhibition of STAT signaling by platinum drugs contributes to their anti-cancer activity.

Hato SV, Figdor CG, Takahashi S, Pen AE, Halilovic A, Bol KF, Vasaturo A, Inoue Y, de Haas N, Verweij D, Van Herpen CML, Kaanders JH, van Krieken JHJM, Van Laarhoven HWM, Hooijer GKJ, Punt CJA, Asai A, de Vries IJM, Lesterhuis WJ.

Oncotarget. 2017 May 7;8(33):54434-54443. doi: 10.18632/oncotarget.17661. eCollection 2017 Aug 15.

24.

Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database.

Salas S, Resseguier N, Blay JY, Le Cesne A, Italiano A, Chevreau C, Rosset P, Isambert N, Soulie P, Cupissol D, Delcambre C, Bay JO, Dubray-Longeras P, Krengli M, De Bari B, Villa S, Kaanders JHAM, Torrente S, Pasquier D, Thariat JO, Myroslav L, Sole CV, Dincbas HF, Habboush JY, Zilli T, Dragan T, Khan R K, Ugurluer G, Cena T, Duffaud F, Penel N, Bertucci F, Ranchere-Vince D, Terrier P, Bonvalot S, Macagno N, Lemoine C, Lae M, Coindre JM, Bouvier C.

Ann Oncol. 2017 Aug 1;28(8):1979-1987. doi: 10.1093/annonc/mdx250.

PMID:
28838212
25.

Automated IMRT planning in Pinnacle : A study in head-and-neck cancer.

Kusters JMAM, Bzdusek K, Kumar P, van Kollenburg PGM, Kunze-Busch MC, Wendling M, Dijkema T, Kaanders JHAM.

Strahlenther Onkol. 2017 Dec;193(12):1031-1038. doi: 10.1007/s00066-017-1187-9. Epub 2017 Aug 2. Erratum in: Strahlenther Onkol. 2017 Dec;193(12 ):1077-1078.

PMID:
28770294
26.

Interim 18F-FDG PET/CT During Chemoradiation Therapy in the Management of Head and Neck Cancer Patients: A Systematic Review.

Garibaldi C, Ronchi S, Cremonesi M, Gilardi L, Travaini L, Ferrari M, Alterio D, Kaanders JHAM, Ciardo D, Orecchia R, Jereczek-Fossa BA, Grana CM.

Int J Radiat Oncol Biol Phys. 2017 Jul 1;98(3):555-573. doi: 10.1016/j.ijrobp.2017.02.217. Epub 2017 Mar 4. Review.

PMID:
28581396
27.

Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma.

van den Bosch S, Dijkema T, Kunze-Busch MC, Terhaard CH, Raaijmakers CP, Doornaert PA, Hoebers FJ, Vergeer MR, Kreike B, Wijers OB, Oyen WJ, Kaanders JH.

BMC Cancer. 2017 Mar 21;17(1):208. doi: 10.1186/s12885-017-3195-7.

28.

Reirradiation of head and neck cancer: Long-term disease control and toxicity.

Bots WTC, van den Bosch S, Zwijnenburg EM, Dijkema T, van den Broek GB, Weijs WLJ, Verhoef LCG, Kaanders JHAM.

Head Neck. 2017 Jun;39(6):1122-1130. doi: 10.1002/hed.24733. Epub 2017 Mar 6.

29.

The efficacy of hyperbaric oxygen therapy related to the clinical stage of osteoradionecrosis of the mandible.

Dieleman FJ, Phan TTT, van den Hoogen FJA, Kaanders JHAM, Merkx MAW.

Int J Oral Maxillofac Surg. 2017 Apr;46(4):428-433. doi: 10.1016/j.ijom.2016.12.004. Epub 2016 Dec 30.

PMID:
28043745
30.

Interaction between hypoxia, AKT and HIF-1 signaling in HNSCC and NSCLC: implications for future treatment strategies.

Stegeman H, Span PN, Peeters WJ, Verheijen MM, Grénman R, Meijer TW, Kaanders JH, Bussink J.

Future Sci OA. 2016 Jan 29;2(1):FSO84. doi: 10.4155/fso.15.84. eCollection 2016 Mar.

31.

Engineered microparticles delivering oxygen to enhance radiotherapy efficacy.

Span PN, Bussink J, Kaanders JH.

Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):E8009. Epub 2016 Dec 7. No abstract available.

32.

Human papillomavirus detection in fine needle aspiration cytology of lymph node metastasis of head and neck squamous cell cancer.

Takes RP, Kaanders JH, van Herpen CM, Merkx MA, Slootweg PJ, Melchers WJ.

J Clin Virol. 2016 Dec;85:22-26. doi: 10.1016/j.jcv.2016.10.008. Epub 2016 Oct 27.

33.

Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicentric in silico ROCOCO trial.

Eekers DBP, Roelofs E, Jelen U, Kirk M, Granzier M, Ammazzalorso F, Ahn PH, Janssens GORJ, Hoebers FJP, Friedmann T, Solberg T, Walsh S, Troost EGC, Kaanders JHAM, Lambin P.

Radiother Oncol. 2016 Dec;121(3):387-394. doi: 10.1016/j.radonc.2016.08.020. Epub 2016 Sep 14.

34.

Adverse effect of smoking on prognosis in human papillomavirus-associated oropharyngeal carcinoma.

Liskamp CP, Janssens GO, Bussink J, Melchers WJ, Kaanders JH, Verhoef CG.

Head Neck. 2016 Dec;38(12):1780-1787. doi: 10.1002/hed.24516. Epub 2016 Jun 1.

PMID:
27248701
35.

Quality-of-life after radiotherapy for advanced laryngeal cancer: Results of a phase III trial of the Dutch Head and Neck Society.

Janssens GO, Langendijk JA, Terhaard CH, Doornaert PA, van den Ende P, de Jong MA, Takes RP, Span PN, Kaanders JH.

Radiother Oncol. 2016 May;119(2):213-20. doi: 10.1016/j.radonc.2016.02.023. Epub 2016 May 8.

PMID:
27165613
36.

Patterns of Recurrence in Electively Irradiated Lymph Node Regions After Definitive Accelerated Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma.

van den Bosch S, Dijkema T, Verhoef LC, Zwijnenburg EM, Janssens GO, Kaanders JH.

Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):766-74. doi: 10.1016/j.ijrobp.2015.12.002. Epub 2015 Dec 13.

PMID:
26972649
37.

Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study.

Driessen CM, de Boer JP, Gelderblom H, Rasch CR, de Jong MA, Verbist BM, Melchers WJ, Tesselaar ME, van der Graaf WT, Kaanders JH, van Herpen CM.

Eur J Cancer. 2016 Jan;52:77-84. doi: 10.1016/j.ejca.2015.09.024. Epub 2015 Dec 1.

38.

Degree of nephrotoxicity after intermediate- or high-dose cisplatin-based chemoradiotherapy in patients with locally advanced head and neck cancer.

Driessen CM, Uijen MJ, van der Graaf WT, van Opstal CC, Kaanders JH, Nijenhuis T, van Herpen CM.

Head Neck. 2016 Apr;38 Suppl 1:E1575-81. doi: 10.1002/hed.24281. Epub 2015 Nov 28.

PMID:
26614010
39.

Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: A prospective analysis.

Cox MC, Kusters JM, Gidding CE, Schieving JH, van Lindert EJ, Kaanders JH, Janssens GO.

Radiat Oncol. 2015 Nov 24;10:241. doi: 10.1186/s13014-015-0547-9.

40.

Effectiveness and toxicity of hypofractionated high-dose intensity-modulated radiotherapy versus 2- and 3-dimensional radiotherapy in incurable head and neck cancer.

van Beek KM, Kaanders JH, Janssens GO, Takes RP, Span PN, Verhoef CG.

Head Neck. 2016 Apr;38 Suppl 1:E1264-70. doi: 10.1002/hed.24203. Epub 2015 Sep 2.

PMID:
26332196
41.

Cognitive function, depression, fatigue and quality of life among long-term survivors of head and neck cancer.

Wilbers J, Kappelle AC, Versteeg L, Tuladhar AM, Steens SCA, Meijer FJA, Boogerd W, Dorresteijn LD, Kaanders JH, Kessels RPC, van Dijk EJ.

Neurooncol Pract. 2015 Sep;2(3):144-150. doi: 10.1093/nop/npv012. Epub 2015 May 7.

42.

Epidermal growth factor receptor imaging in human head and neck cancer xenografts.

van Dijk LK, Boerman OC, Kaanders JH, Bussink J.

Acta Oncol. 2015;54(9):1263-7. doi: 10.3109/0284186X.2015.1063778. Epub 2015 Aug 6. Review.

PMID:
26248024
43.

PET of EGFR with (64) Cu-cetuximab-F(ab')2 in mice with head and neck squamous cell carcinoma xenografts.

van Dijk LK, Yim CB, Franssen GM, Kaanders JH, Rajander J, Solin O, Grönroos TJ, Boerman OC, Bussink J.

Contrast Media Mol Imaging. 2016 Jan-Feb;11(1):65-70. doi: 10.1002/cmmi.1659. Epub 2015 Aug 4.

PMID:
26242487
44.

Treatment of T3 laryngeal cancer in the Netherlands: a national survey.

Doornaert P, Terhaard CH, Kaanders JH; Dutch National Platform Radiotherapy Head and Neck Cancer.

Radiat Oncol. 2015 Jun 26;10:134. doi: 10.1186/s13014-015-0440-6.

45.

PET Imaging in Head and Neck Cancer Patients to Monitor Treatment Response: A Future Role for EGFR-Targeted Imaging.

van Dijk LK, Boerman OC, Kaanders JH, Bussink J.

Clin Cancer Res. 2015 Aug 15;21(16):3602-9. doi: 10.1158/1078-0432.CCR-15-0348. Epub 2015 Apr 30. Review.

46.

Magnetic resonance imaging of the carotid artery in long-term head and neck cancer survivors treated with radiotherapy.

Wilbers J, Meijer FJ, Kappelle AC, Kaanders JH, Boogerd W, Dorresteijn LD, van Dijk EJ, Steens SC.

Acta Oncol. 2015;54(8):1175-80. doi: 10.3109/0284186X.2015.1023901. Epub 2015 Apr 1.

PMID:
25831144
47.

111In-cetuximab-F(ab')2 SPECT and 18F-FDG PET for prediction and response monitoring of combined-modality treatment of human head and neck carcinomas in a mouse model.

van Dijk LK, Boerman OC, Franssen GM, Kaanders JH, Bussink J.

J Nucl Med. 2015 Feb;56(2):287-92. doi: 10.2967/jnumed.114.148296. Epub 2014 Dec 31.

48.

Normalcy of food intake in patients with head and neck cancer supported by combined dietary counseling and swallowing therapy: A randomized clinical trial.

van den Berg MG, Kalf JG, Hendriks JC, Takes RP, van Herpen CM, Wanten GJ, Drenth JP, Kaanders JH, Merkx MA.

Head Neck. 2016 Apr;38 Suppl 1:E198-206. doi: 10.1002/hed.23970. Epub 2015 Jun 16.

PMID:
25533021
49.

Progression of carotid intima media thickness after radiotherapy: a long-term prospective cohort study.

Wilbers J, Dorresteijn LD, Haast R, Hoebers FJ, Kaanders JH, Boogerd W, van Werkhoven ED, Nowee ME, Hansen HH, de Korte CL, Kappelle AC, van Dijk EJ.

Radiother Oncol. 2014 Dec;113(3):359-63. doi: 10.1016/j.radonc.2014.10.012. Epub 2014 Nov 14.

PMID:
25466374
50.

Improving chemoradiation efficacy by PI3-K/AKT inhibition.

Stegeman H, Span PN, Kaanders JH, Bussink J.

Cancer Treat Rev. 2014 Dec;40(10):1182-91. doi: 10.1016/j.ctrv.2014.09.005. Epub 2014 Oct 5. Review.

PMID:
25312653

Supplemental Content

Loading ...
Support Center